Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

The natural history of moyamoya in a North American adult cohort.

Gross BA, Du R.

J Clin Neurosci. 2013 Jan;20(1):44-8. doi: 10.1016/j.jocn.2012.08.002. Epub 2012 Nov 10.

PMID:
23146211
2.

Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.

Liu XJ, Zhang D, Wang S, Zhao YL, Teo M, Wang R, Cao Y, Ye X, Kang S, Zhao JZ.

J Neurosurg. 2015 Feb;122(2):392-9. doi: 10.3171/2014.10.JNS132369. Epub 2014 Nov 28.

PMID:
25423267
3.

Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.

Bao XY, Duan L, Li DS, Yang WZ, Sun WJ, Zhang ZS, Zong R, Han C.

Cerebrovasc Dis. 2012;34(4):305-13. doi: 10.1159/000343225. Epub 2012 Nov 8.

PMID:
23146868
4.

The natural clinical course of hemodynamically stable adult moyamoya disease.

Cho WS, Chung YS, Kim JE, Jeon JP, Son YJ, Bang JS, Kang HS, Sohn CH, Oh CW.

J Neurosurg. 2015 Jan;122(1):82-9. doi: 10.3171/2014.9.JNS132281.

PMID:
25361479
5.

Pediatric stroke among Hong Kong Chinese subjects.

Chung B, Wong V.

Pediatrics. 2004 Aug;114(2):e206-12.

PMID:
15286258
6.

A survey of moyamoya disease in Hawaii.

Graham JF, Matoba A.

Clin Neurol Neurosurg. 1997 Oct;99 Suppl 2:S31-5.

PMID:
9409401
7.

Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review.

Kleinloog R, Regli L, Rinkel GJ, Klijn CJ.

J Neurol Neurosurg Psychiatry. 2012 May;83(5):531-6. doi: 10.1136/jnnp-2011-301387. Epub 2012 Feb 29. Review.

PMID:
22378916
8.

Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.

Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY.

Circ Arrhythm Electrophysiol. 2012 Apr;5(2):312-8. doi: 10.1161/CIRCEP.111.967000. Epub 2012 Feb 7.

9.

Moyamoya disorder in the United States.

Starke RM, Crowley RW, Maltenfort M, Jabbour PM, Gonzalez LF, Tjoumakaris SI, Randazzo CG, Rosenwasser RH, Dumont AS.

Neurosurgery. 2012 Jul;71(1):93-9. doi: 10.1227/NEU.0b013e318253ab8e.

PMID:
22418580
10.

Clinical features and disease progression in moyamoya disease patients with Graves disease.

Chen JB, Lei D, He M, Sun H, Liu Y, Zhang H, You C, Zhou LX.

J Neurosurg. 2015 Oct;123(4):848-55. doi: 10.3171/2014.10.JNS141140. Epub 2015 Apr 10. Erratum in: J Neurosurg. 2015 Dec;123(6):1608. Zhou, Ling-Xue [corrected to Zhou, Liang-Xue].

PMID:
25859801
11.

Pregnancy and delivery in moyamoya disease: results of a nationwide survey in Japan.

Takahashi JC, Ikeda T, Iihara K, Miyamoto S.

Neurol Med Chir (Tokyo). 2012;52(5):304-10.

12.

Clinical features and outcome in North American adults with moyamoya phenomenon.

Hallemeier CL, Rich KM, Grubb RL Jr, Chicoine MR, Moran CJ, Cross DT 3rd, Zipfel GJ, Dacey RG Jr, Derdeyn CP.

Stroke. 2006 Jun;37(6):1490-6. Epub 2006 Apr 27.

13.

Cerebrovascular collaterals correlate with disease severity in adult North American patients with Moyamoya disease.

Strother MK, Anderson MD, Singer RJ, Du L, Moore RD, Shyr Y, Ladner TR, Arteaga D, Day MA, Clemmons PF, Donahue MJ.

AJNR Am J Neuroradiol. 2014 Jul;35(7):1318-24. doi: 10.3174/ajnr.A3883. Epub 2014 Mar 20.

14.

Symptomatic Moyamoya disease: clinical features and outcome after indirect bypass surgery in four French adults.

Derex L, Doumbé J, Kouamé-Assouan AE, Pelissou-Guyotat I, Morel C, Hermier M, Nighoghossian N, Trouillas P.

J Neurol Sci. 2010 Jan 15;288(1-2):92-5. doi: 10.1016/j.jns.2009.09.031. Epub 2009 Oct 17.

PMID:
19840882
15.

Sex differences in clinical presentation and treatment outcomes in Moyamoya disease.

Khan N, Achrol AS, Guzman R, Burns TC, Dodd R, Bell-Stephens T, Steinberg GK.

Neurosurgery. 2012 Sep;71(3):587-93; discussion 593. doi: 10.1227/NEU.0b013e3182600b3c.

PMID:
22718024
16.

The risk of stroke after spinal fusion surgery: a national cohort study.

Wu JC, Chen YC, Liu L, Chen TJ, Huang WC, Thien PF, Cheng H, Lo SS.

Spine J. 2012 Jun;12(6):492-9. doi: 10.1016/j.spinee.2012.05.008. Epub 2012 Jun 15.

PMID:
22703754
17.

Coexisting diseases of moyamoya vasculopathy.

Wei YC, Liu CH, Chang TY, Chin SC, Chang CH, Huang KL, Chang YJ, Peng TI, Lee TH.

J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1344-50. doi: 10.1016/j.jstrokecerebrovasdis.2013.11.008. Epub 2014 Jan 25.

PMID:
24468071
18.

Primary central nervous system vasculitis and moyamoya disease: similarities and differences.

Kraemer M, Berlit P.

J Neurol. 2010 May;257(5):816-9. doi: 10.1007/s00415-009-5425-7.

PMID:
20037765
19.

Epidemiological and clinical features of moyamoya disease in the USA.

Kainth D, Chaudhry SA, Kainth H, Suri FK, Qureshi AI.

Neuroepidemiology. 2013;40(4):282-7. doi: 10.1159/000345957. Epub 2013 Feb 23.

PMID:
23445954
20.

Ischemic stroke in a postpartum patient: understanding the epidemiology, pathogenesis, and outcome of Moyamoya disease.

Ishimori ML, Cohen SN, Hallegua DS, Moser FG, Weisman MH.

Semin Arthritis Rheum. 2006 Feb;35(4):250-9. Review.

PMID:
16461070

Supplemental Content

Support Center